A detailed history of Renaissance Investment Group LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Renaissance Investment Group LLC holds 40,641 shares of NVO stock, worth $4.68 Million. This represents 1.31% of its overall portfolio holdings.

Number of Shares
40,641
Previous 39,438 3.05%
Holding current value
$4.68 Million
Previous $5.06 Million 14.58%
% of portfolio
1.31%
Previous 1.2%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 10, 2024

BUY
$122.71 - $146.91 $147,620 - $176,732
1,203 Added 3.05%
40,641 $5.8 Million
Q1 2024

Apr 29, 2024

BUY
$102.11 - $135.92 $443,565 - $590,436
4,344 Added 12.38%
39,438 $5.06 Million
Q4 2023

Jan 09, 2024

BUY
$87.78 - $105.45 $2.65 Million - $3.18 Million
30,186 Added 615.04%
35,094 $3.63 Million
Q3 2023

Oct 10, 2023

BUY
$90.94 - $199.54 $221,347 - $485,680
2,434 Added 98.38%
4,908 $446,000
Q1 2023

Apr 05, 2023

SELL
$132.34 - $159.14 $3,176 - $3,819
-24 Reduced 0.96%
2,474 $393,000
Q4 2022

Jan 11, 2023

SELL
$102.55 - $135.33 $48,813 - $64,417
-476 Reduced 16.01%
2,498 $0
Q3 2022

Oct 25, 2022

BUY
$95.28 - $116.93 $38,683 - $47,473
406 Added 15.81%
2,974 $317,000
Q4 2021

Feb 04, 2022

BUY
$95.88 - $117.08 $6,519 - $7,961
68 Added 2.72%
2,568 $288,000
Q2 2021

Jul 08, 2021

BUY
$67.66 - $84.76 $169,150 - $211,900
2,500 New
2,500 $209,000
Q2 2019

Jul 17, 2019

SELL
$46.79 - $52.47 $196,330 - $220,164
-4,196 Closed
0 $0
Q1 2019

Apr 19, 2019

BUY
$46.36 - $52.63 $194,526 - $220,835
4,196 New
4,196 $219,000
Q2 2018

Jul 27, 2018

SELL
$44.29 - $50.42 $186,018 - $211,764
-4,200 Closed
0 $0
Q1 2018

Apr 16, 2018

SELL
$48.49 - $58.14 $2,424 - $2,907
-50 Reduced 1.18%
4,200 $207,000
Q4 2017

Jan 03, 2018

SELL
$47.53 - $53.73 $2,376 - $2,686
-50 Reduced 1.16%
4,250 $228,000
Q3 2017

Oct 12, 2017

BUY
$41.15 - $49.22 $176,945 - $211,646
4,300
4,300 $207,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $260B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Renaissance Investment Group LLC Portfolio

Follow Renaissance Investment Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Investment Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Investment Group LLC with notifications on news.